Rafferty Asset Management, LLC Fate Therapeutics Inc Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 214,425 shares of FATE stock, worth $355,945. This represents 0.0% of its overall portfolio holdings.

Number of Shares

214,425

Previous 250,793 14.5%

Holding current value

$355,945

Previous $822,000 8.76%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.12 - $5.57 $113,468 - $202,569	-36,368 Reduced 14.5%	214,425 $750,000
Q2 2024 Aug 13, 2024	SELL	$3.26 - $7.08 $1.56 Million - $3.39 Million	-478,864 Reduced 65.63%	250,793 $822,000
Q1 2024 May 13, 2024	BUY	$3.54 - $8.35 $2.58 Million - $6.09 Million	729,657 New	729,657 $5.36 Million
Q2 2023 Aug 11, 2023	SELL	$4.76 - $6.59 $2.09 Million - $2.89 Million	-438,845 Reduced 31.48%	955,120 $4.55 Million
Q1 2023 May 11, 2023	BUY	$4.24 - $11.12 $4.1 Million - $10.8 Million	967,382 Added 226.77%	1,393,965 $7.95 Million
Q4 2022 Feb 13, 2023	BUY	$9.86 - $23.83 $1.78 Million - $4.29 Million	180,108 Added 73.07%	426,583 $4.3 Million
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $1.13 Million - $1.93 Million	53,651 Added 27.82%	246,475 $5.52 Million
Q2 2022 Aug 12, 2022	BUY	$17.78 - $42.39 $594,456 - $1.42 Million	33,434 Added 20.98%	192,824 $4.78 Million
Q1 2022 May 13, 2022	BUY	$29.67 - $60.28 $1.55 Million - $3.14 Million	52,122 Added 48.59%	159,390 $6.18 Million
Q4 2021 Feb 10, 2022	BUY	$47.84 - $64.34 $2.95 Million - $3.97 Million	61,723 Added 135.52%	107,268 $6.28 Million
Q3 2021 Nov 10, 2021	BUY	$59.27 - $95.73 $976,651 - $1.58 Million	16,478 Added 56.69%	45,545 $2.7 Million
Q2 2021 Aug 10, 2021	SELL	$67.25 - $92.52 $3.75 Million - $5.15 Million	-55,708 Reduced 65.71%	29,067 $2.52 Million
Q1 2021 May 10, 2021	BUY	$72.16 - $117.4 $4.89 Million - $7.96 Million	67,811 Added 399.73%	84,775 $6.99 Million
Q4 2020 Feb 10, 2021	SELL	$38.09 - $100.95 $1.61 Million - $4.26 Million	-42,159 Reduced 71.31%	16,964 $1.54 Million
Q3 2020 Nov 13, 2020	BUY	$30.41 - $40.5 $853,243 - $1.14 Million	28,058 Added 90.32%	59,123 $2.36 Million
Q2 2020 Aug 07, 2020	BUY	$20.21 - $35.23 $627,823 - $1.09 Million	31,065 New	31,065 $1.07 Million
Q1 2020 May 15, 2020	SELL	$17.28 - $31.88 $1.04 Million - $1.91 Million	-60,015 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$13.39 - $20.73 $1.28 Million - $1.98 Million	-95,601 Reduced 61.43%	60,015 $1.17 Million
Q3 2019 Nov 14, 2019	BUY	$15.47 - $22.5 $762,160 - $1.11 Million	49,267 Added 46.33%	155,616 $2.42 Million
Q2 2019 Aug 09, 2019	SELL	$15.61 - $20.44 $796 - $1,042	-51 Reduced 0.05%	106,349 $2.16 Million
Q1 2019 May 15, 2019	BUY	$13.15 - $18.71 $1.4 Million - $1.99 Million	106,400 New	106,400 $1.87 Million

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $161M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Fate Therapeutics Inc Transaction History